{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:25:39Z","timestamp":1790799939553,"version":"4.1.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Among cancer surgeries, patients requiring open radical cystectomy have the highest risk of red blood cell (RBC) transfusion. Prophylactic tranexamic acid (TXA) reduces blood loss during cardiac and orthopedic surgery, and it is possible that similar effects of TXA would be observed during radical cystectomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine whether TXA, administered before incision and for the duration of radical cystectomy, reduced the number of RBC transfusions received by patients up to 30 days after surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>The Tranexamic Acid During Cystectomy Trial (TACT) was a double-blind, placebo-controlled, randomized clinical trial with enrollment between June 2013 and January 2021. This multicenter trial was conducted in 10 academic centers. A consecutive sample of patients was eligible if the patients had a planned open radical cystectomy for the treatment of bladder cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>Before incision, patients in the intervention arm received a loading dose of intravenous TXA, 10 mg\/kg, followed by a maintenance infusion of 5 mg\/kg per hour for the duration of the surgery. In the control arm, patients received indistinguishable matching placebo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The primary outcome was receipt of RBC transfusion up to 30 days after surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 386 patients were assessed for eligibility, and 33 did not meet eligibility. Of 353 randomized patients (median [IQR] age, 69 [62-75] years; 263 male [74.5%]), 344 were included in the intention-to-treat analysis. RBC transfusion up to 30 days occurred in 64 of 173 patients (37.0%) in the TXA group and 64 of 171 patients (37.4%) in the placebo group (relative risk, 0.99; 95% CI, 0.83-1.18). There were no differences in secondary outcomes among the TXA group vs placebo group including mean (SD) number of RBC units transfused (0.9\u2009[1.5] U vs 1.1\u2009[1.8] U; <jats:italic>P<\/jats:italic>\u2009=\u2009.43), estimated blood loss (927\u2009[733] mL vs 963\u2009[624] mL; <jats:italic>P<\/jats:italic>\u2009=\u2009.52), intraoperative transfusion (28.3% [49 of 173] vs 24.0% [41 of 171]; <jats:italic>P<\/jats:italic>\u2009=\u2009.08), or venous thromboembolic events (3.5% [6 of 173] vs 2.9% [5 of 171]; <jats:italic>P<\/jats:italic>\u2009=\u2009.57). Non\u2013transfusion-related adverse events were similar between groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Results of this randomized clinical trial reveal that TXA did not reduce blood transfusion in patients undergoing open radical cystectomy for bladder cancer. Based on this trial, routine use of TXA during open radical cystectomy is not recommended.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT01869413\">NCT01869413<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2024.4183","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T15:34:24Z","timestamp":1727883264000},"page":"1355","source":"Crossref","is-referenced-by-count":17,"title":["Tranexamic Acid During Radical Cystectomy"],"prefix":"10.1001","volume":"159","author":[{"given":"Rodney H.","family":"Breau","sequence":"first","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke T.","family":"Lavall\u00e9e","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Cagiannos","sequence":"additional","affiliation":[{"name":"Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Momoli","sequence":"additional","affiliation":[{"name":"School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Bryson","sequence":"additional","affiliation":[{"name":"Departments of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salmaan","family":"Kanji","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Morash","sequence":"additional","affiliation":[{"name":"Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis F.","family":"Turgeon","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Critical Care Medicine, Division of Critical Care Medicine, Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"},{"name":"Population Health and Optimal Health Practices Research Unit (Trauma-Emergency-Critical Care Medicine), CHU de Qu\u00e9bec\u2014Universit\u00e9 Laval Research Center, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Oncology and Haematology, Cancercare Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Houston","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"Department of Medical Oncology and Haematology, Cancercare Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"McIsaac","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"},{"name":"Departments of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeeta","family":"Mallick","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Knoll","sequence":"additional","affiliation":[{"name":"Department of Medicine (Nephrology), The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Izawa","sequence":"additional","affiliation":[{"name":"Department of Surgery & Oncology, Division of Urology, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[{"name":"University of Montreal Hospital Center (CHUM), Montreal Cancer Institute\/CRCHUM, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wassim","family":"Kassouf","sequence":"additional","affiliation":[{"name":"Department of Surgery (Urology), McGill University Health Center, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Fradet","sequence":"additional","affiliation":[{"name":"Department of Surgery (Urology), CHU de Qu\u00e9bec \u2013 Universit\u00e9 Laval, Qu\u00e9bec City, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Rendon","sequence":"additional","affiliation":[{"name":"Department of Urology, Dalhousie University and Nova Scotia Health Authority, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Shayegan","sequence":"additional","affiliation":[{"name":"Division of Urology, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Fairey","sequence":"additional","affiliation":[{"name":"Division of Urology, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrel E.","family":"Drachenberg","sequence":"additional","affiliation":[{"name":"Urologic Oncologist, Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Fergusson","sequence":"additional","affiliation":[{"name":"Ottawa Hospital Research Institute, Ottawa, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"soi240071r1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001886.pub3","article-title":"Antifibrinolytic use for minimizing perioperative allogeneic blood transfusion.","author":"Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"soi240071r2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tmrv.2019.10.001","article-title":"Efficacy and safety of tranexamic acid in major noncardiac surgeries at high risk for transfusion: a systematic review and meta-analysis.","volume":"34","author":"Houston","year":"2020","journal-title":"Transfus Med Rev"},{"issue":"13","key":"soi240071r3","first-page":"e642","article-title":"The top 20 surgical procedures associated with the highest risk for blood transfusion.","volume":"107","author":"Montroy","year":"2020","journal-title":"Br J Surg"},{"issue":"1","key":"soi240071r4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tmrv.2020.08.001","article-title":"Evaluation of transfusion practices in noncardiac surgeries at high risk for red blood cell transfusion: a retrospective cohort study.","volume":"35","author":"Houston","year":"2021","journal-title":"Transfus Med Rev"},{"issue":"3","key":"soi240071r5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tmrv.2017.03.002","article-title":"The safety and efficacy of lysine analogues in cancer patients: a systematic review and meta-analysis.","volume":"31","author":"Montroy","year":"2017","journal-title":"Transfus Med Rev"},{"issue":"5-6","key":"soi240071r6","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.5489\/cuaj.1002","article-title":"Blood transfusion and hemostatic agents used during radical cystectomy.","volume":"7","author":"Punjani","year":"2013","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"soi240071r7","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.3747\/co.27.6613","article-title":"Lysine analogue use during cancer surgery: a survey from a Canadian tertiary care center.","volume":"27","author":"Montroy","year":"2020","journal-title":"Curr Oncol"},{"issue":"1","key":"soi240071r8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13063-018-2626-3","article-title":"Tranexamic acid vs placebo to prevent blood transfusion during radical cystectomy for bladder cancer (TACT): study protocol for a randomized controlled trial.","volume":"19","author":"Breau","year":"2018","journal-title":"Trials"},{"issue":"21","key":"soi240071r9","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMoa2201171","article-title":"Tranexamic acid in patients undergoing noncardiac surgery.","volume":"386","author":"Devereaux","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"soi240071r11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ejogrb.2007.04.003","article-title":"Intravenous tranexamic acid use in myomectomy: a prospective, randomized, double-blind, placebo-controlled study.","volume":"137","author":"Caglar","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"10241","key":"soi240071r12","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-hour infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial.","volume":"395","author":"HALT-IT Trial Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"9734","key":"soi240071r13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial.","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"10139","key":"soi240071r14","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/S0140-6736(18)30996-6","article-title":"Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, noninferiority trial.","volume":"391","author":"Parekh","year":"2018","journal-title":"Lancet"},{"issue":"21","key":"soi240071r15","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1001\/jama.2022.7393","article-title":"Effect of robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy on 90-day morbidity and mortality among patients with bladder cancer: a randomized clinical trial.","volume":"327","author":"Catto","year":"2022","journal-title":"JAMA"},{"issue":"19","key":"soi240071r16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003685","article-title":"Efficacy and safety of stroke volume variation-guided fluid therapy for reducing blood loss and transfusion requirements during radical cystectomy: a randomized clinical trial.","volume":"95","author":"Kong","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"soi240071r17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.eururo.2013.08.046","article-title":"Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: results of a prospective randomized trial.","volume":"66","author":"Wuethrich","year":"2014","journal-title":"Eur Urol"},{"key":"soi240071r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110373","article-title":"Fibrinogen prophylaxis for reducing perioperative bleeding in patients undergoing radical cystectomy: a double-blind, placebo-controlled, randomized trial.","volume":"73","author":"Fathi","year":"2021","journal-title":"J Clin Anesth"},{"issue":"1","key":"soi240071r19","doi-asserted-by":"publisher","first-page":"45.e11","DOI":"10.1016\/j.urolonc.2013.06.006","article-title":"Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs stapling device.","volume":"32","author":"Thompson","year":"2014","journal-title":"Urol Oncol"},{"key":"soi240071r10","volume-title":"Thromboprophylaxis in Urological Surgery","author":"Tikkinen","year":"2017"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2824307\/jamasurgery_breau_2024_oi_240071_1733854587.62365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T20:35:04Z","timestamp":1733949304000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2824307"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2024.4183","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}